Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-4 ل  4 نتائج ل ""Small Cell Lung Carcinoma drug therapy""

فلترة النتائج

Subject : rc254-282
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Characteristics and overall survival of patients with early‐stage non‐small cell lung cancer: A cohort study in Denmark: A cohort study in Denmark

Subjects: non‐small cell lung cancer; Lung Neoplasms; Protein Kinase Inhibitors/therapeutic use

  • Source: Cancer MedCancer Medicine, Vol 12, Iss 1, Pp 30-37 (2023)Ehrenstein, V, Eriksen, K, Taylor, A, Servidio, L & Jakobsen, E 2023, ' Characteristics and overall survival of patients with

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

Subjects: non-small cell lung carcinoma -- drug therapy -- genetics; capmatinib; MET exon 14 skipping mutation

  • Source: Ther Adv Med OncolTherapeutic Advances in Medical Oncology, Vol 14 (2022)Illini, O, Fabikan, H, Swalduz, A, Vikström, A, Krenbek, D, Schumacher, M, Dudnik, E, Studnicka, M, Öhman, R,

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Subjects: molecular targeted therapy; tyrosine kinase inhibitor (TKI); RET gene fusions

  • Source: Ther Adv Med OncolRepositorio Institucional de la Consejería de Sanidad de la Comunidad de MadridConsejería de Sanidad de la Comunidad de MadridTherapeutic Advances in Medical

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials

Subjects: Clinical/Translational Cancer Immunotherapy; Lung Neoplasms; Neoplasms. Tumors. Oncology. Including cancer and carcinogens

  • Source: J Immunother CancerJournal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-4 ل  4 نتائج ل ""Small Cell Lung Carcinoma drug therapy""